University of California San Francisco Give to UCSF

Archived Content: This historical record is not updated. To request an accessible version of this page or its resources, contact calendar@ucsf.edu.

 

Ray and Dagmar Dolby Regeneration Medicine Building, Boardroom View map

35 Medical Center Way

View map

Join us for our Stem Cell Genome Editing Series, which highlights advances in genome editing for stem cell biology and therapeutic development. The series reflects the Center for Genome Surgery’s mission to address critical challenges in gene editing and aligns with the UCSF Broad Stem Cell Center’s vision to Discover, Engineer, Heal. This series takes place on the second and fourth Tuesdays of each month (with occasional holiday adjustments) and begins with research presentations, followed by an open Q&A. 

At our March 24 session, Peter Bruno, PhD, will present "Synthetic biology to enable antigen presentation screening systems." Antigen presentation lies at the core of our adaptive immune responses. How can we design better systems for understanding this process? 

Speaker Lineup
March 24 | Peter Bruno "Synthetic biology to enable antigen presentation screening systems"
April 28 | James Gardner "Normothermic perfusion systems as platforms for groundbreaking ex vivo human biology"
May 12 | Seth Shipman "Bacterial Reverse Transcriptases for DNA Donor Generation"

UCSF welcomes all participants to our events. If you need a reasonable accommodation to participate in this event because of a disability, please contact IRMEvents@ucsf.edu as soon as possible.

Event Details

See Who Is Interested

  • Shery
  • Alexandre Sathler
  • Justin Smith
  • Zening Wang

+ 1 People interested in event

User Activity

No recent activity

UCSF promotes the exchange of diverse ideas and perspectives, acknowledging that the views and opinions of our guest speakers on campus are their own and may not reflect the perspective of the University. We embrace free speech in the pursuit of greater understanding, consistent with our obligations as a public university under the First Amendment.

 

Stem Cell Genome Editing Series